Is Baseline Quality of Life Useful for Predicting Survival With Hormone-Refractory Prostate Cancer? A Pooled Analysis of Three Studies of the European Organisation for Research and Treatment of Cancer ...
CULVER CITY, Calif.--(BUSINESS WIRE)--ImmunityBio, Inc. (NASDAQ: IBRX), a clinical-stage immunotherapy company, today announced findings from a Phase 1 study showing that allogeneic cytokine-induced ...
February 22, 2008 — Allogeneic hematopoietic stem cell transplantation (HSCT) has been shown to cause tumor regression in some patients with metastatic renal cell carcinoma, and there is evidence ...
A study published in Cancer Cell by researchers of the Molecular Oncology Program at the Spanish National Cancer Research Centre (CNIO) shows how the elimination of the c-Raf kinase by genetic ...
Looking back at animal and clinical studies published since the 1920s, the notion of rapid regression and stabilization of atherosclerosis in humans has evolved from a fanciful goal to one that might ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results